Research activity

Here is a list of all the research activity pages:

Generic List

Business engagement and technology transfer

The University of Birmingham works with a wide variety of commercial organisations and aims to use the skills, knowledge and expertise of its community to collaborate with the commercial world and add value to businesses and industries globally.

Cancer predisposition pathways

Research group page for Jo Morris's Cancer Predisposition Pathways group in the School of Cancer Sciences, at the University of Birmingham.

Cancer research

Cancer research at the University of Birmingham has particular strengths in leukaemia and lymphoma, paediatric cancer, urological cancers, pancreatic cancer, brain tumours and cancers of the gastrointestinal tract.

Cancer Research UK Clinical Trials Unit (CRCTU)

The University of Birmingham is one of the leading centres in the UK for clinical trials, having a wealth of experience across a wide range of diseases, clinical settings and trial designs. The Birmingham Centre for Clinical Trials (BCCT) brings together clinical trial expertise from across the University and, in particular, the three large, well-established, UKCRC fully-registered Clinical Trials Units. The trials portfolio at the University of Birmingham is supported by a comprehensive expert infrastructure in trial methodology.

Cancer Survivorship

The group page for the Cancer Survivorship group, led by Mike Hawkins, at the University of Birmingham

Cardiovascular Disease

The group page for the Cardiovascular Disease group, led by David Fitzmaurice, at the University of Birmingham.

Cardiovascular Translational Research Group: Myocardial Infarction and Heart Failure

Information on the Cardiovascular Translational Group: Myocardial Ischaemia Reperfusion Injury and Heart Failure Group, led by Dr Melanie Madhani, at the University of Birmingham.

Cardiovascular, Respiratory and Neurological Sciences

Cardiovascular research in the University of Birmingham encompasses studies from the molecular and signalling pathways regulating behaviour of cells of the vasculature, to the functioning of the heart and vessels in animals, to the pathophysiology of heart failure, heart attacks and atrial fibrillation, to the impact of cardiovascular diseases on public health. We are developing ways to inhibit vascular thrombosis and inflammation, optimise blood flow, improve management of those with heart disease, and test the effects of large scale interventions on the region's health.

Careers in Complementary and Alternative Medicine

This study, entitled 'Putting embodied knowledge into practice: a follow up study of graduates from complementary and alternative medicine training courses' is funded by the Economic and Social Research Council , and led by Dr Nicola Gale

Carotid Body and Chemoreceptor Research Group

Information on the Carotid Body and Chemoreceptor Research Group, led by Professor Prem Kumar, Section of Cardiovascular Sciences, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, The University of Birmingham
Displaying 71 to 80 of 684
Previous 6 7 8 9 10 Next